From insights to execution: How advanced AI agents drive improved enterprise decision-making

In many organisations, decision-making still moves at a pace that belongs to an earlier era. Committees deliberate on data from past weeks, slide decks summarize yesterday’s realities and actions are taken long after market conditions shift. The challenge is especially evident in sectors such as pharmaceuticals and life sciences, where complex operations and strict regulatory oversight can slow critical decisions.
This is the paradox of the digital age. Enterprises have invested heavily in data infrastructure, advanced models and real-time analytics, yet their operating rhythm lags behind the speed of change. Insight generation has accelerated but decisions often remain episodic and slow.

That dynamic is changing. Agentic AI, systems capable of perceiving, reasoning, acting and learning, marks a decisive turn from retrospective reporting to continuous, outcome-driven decision loops. In India, 24% of business leaders report active deployment of agentic AI. Early adopters are already showing how human-AI teams expand capacity, unlock creativity and reshape workforce models in ways traditional automation could not deliver.

Agentic AI closes the gap between knowing and doing, embedding governed decision-making directly into the flow of work and compounding improvements over time.

Continuous decision flywheels

Many AI programs stall at the “faster dashboard” stage. Real transformation comes when organizations replace stop-start decision points with loops that sense, reason, act and learn continuously.

Agents stay engaged with internal systems and market signals, weighing changes against operational, financial and regulatory considerations before resources are committed. Low-risk actions can proceed autonomously while higher-risk situations are escalated to human reviewers.

Over time, every completed cycle feeds the organization’s institutional knowledge, making future decisions sharper.
In practice, this approach has delivered dramatic results in complex environments. For example, in supply chain operations for data centers, multiple agents now work in concert: one continuously scans purchase orders for exceptions, another sends targeted alerts to the right teams and a third reconciles mismatches between internal records, supplier updates and carrier reports. 

This reflects a broader shift. By 2030, intelligent agents will be responsible for making and carrying out decisions in about half of all cross‑functional supply chain management operations.

Fast-fail, business-first

Scaling agentic AI is most effective when done with purpose. High performers should be expanded carefully into new workflows, while weaker agents are retired and their performance gaps examined to extract lessons. Each trial, whether it succeeds or fails, becomes input for the next design. This is the essence of rapid prototyping in which progress moves at a pace the organization can manage, keeping capability in step with governance instead of racing ahead unchecked.

To succeed, these systems must be treated as active contributors to the enterprise rather than hidden pieces of infrastructure. Every agent should have a clearly defined role linked directly to business priorities, with boundaries for its authority and clear triggers for when human oversight is required. Evaluations should go beyond technical benchmarks, focusing on decision quality, execution speed and measurable business outcomes. When results fall short, leaders must decide whether to retrain, narrow the scope or remove the system entirely. This approach keeps accountability at the forefront and ensures AI remains aligned with organizational goals rather than drifting into unsupervised autonomy.

In practice, expertise‑led professional services firms such as ZS work with life sciences companies to embed agentic AI into AI‑native business architectures, ensuring that workflows are governed by clear rules and that exceptions are automatically escalated to human decision‑makers. This design builds trust to keep operations compliant and helps decision quality improve with each cycle of use.

Governance as the engine

Responsible use of agentic AI depends on balancing autonomy with clear oversight. This balance comes from designing systems with a few essential disciplines in place. One is cognitive specialisation, where focused models are built for specific domains. Limited scope makes them easier to monitor, audit and refine. Another is coordination, giving agents frameworks to work toward shared goals and resolve conflicts before they disrupt operations.

Finally, real-time control sets adaptive guardrails that check the context and confidence of an action. 
When these elements work together, autonomy can be scaled safely; when they are missing, failures tend to resemble organizational breakdowns more than software glitches. Strong governance thus creates the foundation for meaningful gains.

By 2029, for example, agentic AI could be handling close to four out of every five routine customer service requests without human involvement. That change would ease operational costs significantly and free skilled teams to concentrate on exceptions, innovative problem‑solving and work that has higher value for the business.

The leadership test

Organisations that achieve sustained value from agentic AI treat it as a catalyst for ongoing improvement. Successful organizations invest in stronger data foundations and equip people for roles that demand critical judgment. They keep a close eye on the quality of decisions as well as efficiency, using AI to support human strengths and to catch problems before they escalate. Companies that structure their operations so people and intelligent agents work side by side will be best positioned to compete.

Agentic AI, applied with clear governance, reshapes how decisions are made. The question for leaders is not whether to deploy it, but which decisions merit a tireless, self‑improving partner and how quickly that partnership can be built. This is especially true in complex, high‑stakes sectors such as pharmaceuticals and life sciences, where the ability to act faster, without compromising compliance or oversight, can directly influence innovation cycles, regulatory success and patient outcomes.

Abhisek Halder

---

The author is Abhisek Halder, Office Managing Principal, ZS